{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T08:24:10Z","timestamp":1787387050713,"version":"build-2736575974"},"reference-count":136,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s12325-026-03658-5","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:49:17Z","timestamp":1782845357000},"page":"3786-3809","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sacral Neuromodulation for Refractory Overactive Bladder: Closing the Gaps in Anatomy, Mechanisms, and Parameter Selection"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4439-4542","authenticated-orcid":false,"given":"Daniel P.","family":"Marshall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9728-0341","authenticated-orcid":false,"given":"Isha","family":"Chugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6180-5214","authenticated-orcid":false,"given":"Cindy L.","family":"Amundsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4453-4488","authenticated-orcid":false,"given":"Nazema Y.","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5240-6588","authenticated-orcid":false,"given":"Warren M.","family":"Grill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"issue":"6","key":"3658_CR1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00345-002-0301-4","volume":"20","author":"W Stewart","year":"2003","unstructured":"Stewart W, Van Rooyen J, Cundiff G, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20(6):327\u201336. https:\/\/doi.org\/10.1007\/s00345-002-0301-4.","journal-title":"World J Urol"},{"issue":"5","key":"3658_CR2","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.urology.2010.08.039","volume":"77","author":"KS Coyne","year":"2011","unstructured":"Coyne KS, Sexton CC, Vats V, Thompson C, Kopp ZS, Milsom I. National community prevalence of overactive bladder in the United States stratified by sex and age. Urology. 2011;77(5):1081\u20137. https:\/\/doi.org\/10.1016\/j.urology.2010.08.039.","journal-title":"Urology"},{"issue":"8","key":"3658_CR3","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1111\/j.1532-5415.2011.03492.x","volume":"59","author":"CC Sexton","year":"2011","unstructured":"Sexton CC, Coyne KS, Thompson C, Bavendam T, Chen CI, Markland A. Prevalence and effect on health-related quality of life of overactive bladder in older Americans: results from the epidemiology of lower urinary tract symptoms study. J Am Geriatr Soc. 2011;59(8):1465\u201370. https:\/\/doi.org\/10.1111\/j.1532-5415.2011.03492.x.","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"3658_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/JU.0000000000003985","volume":"212","author":"AP Cameron","year":"2024","unstructured":"Cameron AP, Chung DE, Dielubanza EJ, et al. The AUA\/SUFU guideline on the diagnosis and treatment of idiopathic overactive bladder. J Urol. 2024;212(1):11\u201320. https:\/\/doi.org\/10.1097\/JU.0000000000003985.","journal-title":"J Urol"},{"issue":"1","key":"3658_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s12325-024-03019-0","volume":"42","author":"CL Amundsen","year":"2025","unstructured":"Amundsen CL, Sutherland SE, Kielb SJ, Dmochowski RR. Sacral and implantable tibial neuromodulation for the management of overactive bladder: a systematic review and meta-analysis. Adv Ther. 2025;42(1):10\u201335. https:\/\/doi.org\/10.1007\/s12325-024-03019-0.","journal-title":"Adv Ther"},{"key":"3658_CR6","doi-asserted-by":"publisher","first-page":"1014291","DOI":"10.3389\/fmed.2022.1014291","volume":"9","author":"P Liu","year":"2022","unstructured":"Liu P, Li Y, Shi B, Zhang Q, Guo H. Comparison of different types of therapy for overactive bladder: a systematic review and network meta-analysis. Front Med. 2022;9:1014291. https:\/\/doi.org\/10.3389\/fmed.2022.1014291.","journal-title":"Front Med"},{"issue":"2","key":"3658_CR7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/toxins12020128","volume":"12","author":"CW Lo","year":"2020","unstructured":"Lo CW, Wu MY, Yang SSD, Jaw FS, Chang SJ. Comparing the efficacy of OnabotulinumtoxinA, sacral neuromodulation, and peripheral tibial nerve stimulation as third line treatment for the management of overactive bladder symptoms in adults: systematic review and network meta-analysis. Toxins Basel. 2020;12(2):2. https:\/\/doi.org\/10.3390\/toxins12020128.","journal-title":"Toxins Basel"},{"issue":"S1","key":"3658_CR8","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1002\/nau.20786","volume":"29","author":"NY Siddiqui","year":"2010","unstructured":"Siddiqui NY, Wu JM, Amundsen CL. Efficacy and adverse events of sacral nerve stimulation for overactive bladder: a systematic review. Neurourol Urodyn. 2010;29(S1):S18\u201323. https:\/\/doi.org\/10.1002\/nau.20786.","journal-title":"Neurourol Urodyn"},{"issue":"2","key":"3658_CR9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1080\/17434440.2022.2032655","volume":"19","author":"S Tilborghs","year":"2022","unstructured":"Tilborghs S, De Wachter S. Sacral neuromodulation for the treatment of overactive bladder: systematic review and future prospects. Expert Rev Med Devices. 2022;19(2):161\u201387. https:\/\/doi.org\/10.1080\/17434440.2022.2032655.","journal-title":"Expert Rev Med Devices"},{"issue":"3","key":"3658_CR10","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/S0022-5347(05)00326-5","volume":"175","author":"M Brazzelli","year":"2006","unstructured":"Brazzelli M, Murray A, Fraser C. Efficacy and safety of sacral nerve stimulation for urinary urge incontinence: a systematic review. J Urol. 2006;175(3):835\u201341. https:\/\/doi.org\/10.1016\/S0022-5347(05)00326-5.","journal-title":"J Urol"},{"issue":"3","key":"3658_CR11","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/nau.25600","volume":"44","author":"MA Averbeck","year":"2025","unstructured":"Averbeck MA, Gajewski JB, Finazzi-Agr\u00f2 E, et al. Is our limited understanding of the effects of nerve stimulation resulting in poor outcomes and the need for better \u201crescue programming\u201d in SNM and PTNS, and lost opportunities for new sites of stimulation? ICI-RS 2024. Neurourol Urodyn. 2025;44(3):676\u201382. https:\/\/doi.org\/10.1002\/nau.25600.","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"3658_CR12","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1159\/000280267","volume":"34","author":"RA Schmidt","year":"1979","unstructured":"Schmidt RA, Tanagho EA. Feasibility of controlled micturition through electric stimulation. Urol Int. 1979;34(3):199\u2013230. https:\/\/doi.org\/10.1159\/000280267.","journal-title":"Urol Int"},{"issue":"7","key":"3658_CR13","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41585-024-00967-8","volume":"22","author":"J Krhut","year":"2025","unstructured":"Krhut J, Kobber\u00f8 H, Kanaan R, Fode M, Poulsen M, Zvara P. The mechanism of action of neuromodulation in the treatment of overactive bladder. Nat Rev Urol. 2025;22(7):414\u201326. https:\/\/doi.org\/10.1038\/s41585-024-00967-8.","journal-title":"Nat Rev Urol"},{"issue":"7","key":"3658_CR14","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1111\/ner.13494","volume":"24","author":"TC Dudding","year":"2021","unstructured":"Dudding TC, Lehur PA, S\u00f8rensen M, et al. Reprogramming sacral neuromodulation for sub-optimal outcomes: evidence and recommendations for clinical practice. Neuromodulation. 2021;24(7):1247\u201357. https:\/\/doi.org\/10.1111\/ner.13494.","journal-title":"Neuromodulation"},{"issue":"8","key":"3658_CR15","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1111\/ner.13117","volume":"23","author":"PA Lehur","year":"2020","unstructured":"Lehur PA, S\u00f8rensen M, Dudding TC, et al. Programming algorithms for sacral neuromodulation: clinical practice and evidence\u2014recommendations for day-to-day practice. Neuromodulation. 2020;23(8):1121\u20139. https:\/\/doi.org\/10.1111\/ner.13117.","journal-title":"Neuromodulation"},{"issue":"3","key":"3658_CR16","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/codi.15390","volume":"23","author":"CH Knowles","year":"2021","unstructured":"Knowles CH, De Wachter S, Engelberg S, Lehur P, Matzel KE, Zirpel L. The science behind programming algorithms for sacral neuromodulation. Colorectal Dis. 2021;23(3):592\u2013602. https:\/\/doi.org\/10.1111\/codi.15390.","journal-title":"Colorectal Dis"},{"issue":"2","key":"3658_CR17","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/JU.0000000000003498","volume":"210","author":"BC Gill","year":"2023","unstructured":"Gill BC, Thomas S, Barden L, et al. Intraoperative predictors of sacral neuromodulation implantation and treatment response: results from the ROSETTA trial. J Urol. 2023;210(2):331\u201340. https:\/\/doi.org\/10.1097\/JU.0000000000003498.","journal-title":"J Urol"},{"issue":"4","key":"3658_CR18","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1159\/000513937","volume":"106","author":"R Jairam","year":"2022","unstructured":"Jairam R, Drossaerts J, Marcelissen T, Van Koeveringe G, Vrijens D, Van Kerrebroeck P. Predictive factors in sacral neuromodulation: a systematic review. Urol Int. 2022;106(4):323\u201343. https:\/\/doi.org\/10.1159\/000513937.","journal-title":"Urol Int"},{"issue":"8","key":"3658_CR19","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1016\/j.clinph.2007.05.061","volume":"118","author":"CR Butson","year":"2007","unstructured":"Butson CR, McIntyre CC. Differences among implanted pulse generator waveforms cause variations in the neural response to deep brain stimulation. Clin Neurophysiol. 2007;118(8):1889\u201394. https:\/\/doi.org\/10.1016\/j.clinph.2007.05.061.","journal-title":"Clin Neurophysiol"},{"issue":"4","key":"3658_CR20","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.clinph.2018.01.015","volume":"129","author":"SF Lempka","year":"2018","unstructured":"Lempka SF, Howell B, Gunalan K, Machado AG, McIntyre CC. Characterization of the stimulus waveforms generated by implantable pulse generators for deep brain stimulation. Clin Neurophysiol. 2018;129(4):731\u201342. https:\/\/doi.org\/10.1016\/j.clinph.2018.01.015.","journal-title":"Clin Neurophysiol"},{"issue":"4","key":"3658_CR21","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1097\/MRR.0000000000000492","volume":"44","author":"M Li","year":"2021","unstructured":"Li M, Zhang N, Wu D, Jiang M, You S, Jia Y. Electric nerve stimulation for overactive bladder: an umbrella review. Int J Rehabil Res. 2021;44(4):298\u2013306. https:\/\/doi.org\/10.1097\/MRR.0000000000000492.","journal-title":"Int J Rehabil Res"},{"issue":"6","key":"3658_CR22","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/ner.12981","volume":"22","author":"DR Greenberg","year":"2019","unstructured":"Greenberg DR, Syan R, Young-Lin N, Comiter CV, Enemchukwu E. Outcomes of sacral nerve stimulation for treatment of refractory overactive bladder among octogenarians. Neuromodulation. 2019;22(6):738\u201344. https:\/\/doi.org\/10.1111\/ner.12981.","journal-title":"Neuromodulation"},{"issue":"1","key":"3658_CR23","doi-asserted-by":"publisher","first-page":"111.e1","DOI":"10.1016\/j.ajog.2017.10.006","volume":"218","author":"YM Komesu","year":"2018","unstructured":"Komesu YM, Amundsen CL, Richter HE, et al. Refractory urgency urinary incontinence treatment in women: impact of age on outcomes and complications. Am J Obstet Gynecol. 2018;218(1):111.e1-111.e9. https:\/\/doi.org\/10.1016\/j.ajog.2017.10.006.","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"3658_CR24","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1002\/nau.24965","volume":"41","author":"J Zillioux","year":"2022","unstructured":"Zillioux J, Slopnick EA, Vasavada SP. Third-line therapy for overactive bladder in the elderly: nuances and considerations. Neurourol Urodyn. 2022;41(8):1967\u201374. https:\/\/doi.org\/10.1002\/nau.24965.","journal-title":"Neurourol Urodyn"},{"issue":"4 Part 2","key":"3658_CR25","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.juro.2015.11.034","volume":"195","author":"MD Mason","year":"2016","unstructured":"Mason MD, Stephany HA, Casella DP, et al. Prospective evaluation of sacral neuromodulation in children: outcomes and urodynamic predictors of success. J Urol. 2016;195(4 Part 2):1239\u201344. https:\/\/doi.org\/10.1016\/j.juro.2015.11.034.","journal-title":"J Urol"},{"issue":"5","key":"3658_CR26","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1097\/JU.0000000000000656","volume":"203","author":"HS Harvie","year":"2020","unstructured":"Harvie HS, Amundsen CL, Neuwahl SJ, et al. Cost-effectiveness of sacral neuromodulation versus OnabotulinumtoxinA for refractory urgency urinary incontinence: results of the ROSETTA randomized trial. J Urol. 2020;203(5):969\u201377. https:\/\/doi.org\/10.1097\/JU.0000000000000656.","journal-title":"J Urol"},{"key":"3658_CR27","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2147\/RRU.S89544","volume":"8","author":"T Sukhu","year":"2016","unstructured":"Sukhu T, Kennelly M, Kurpad R. Sacral neuromodulation in overactive bladder: a review and current perspectives. Res Rep Urol. 2016;8:193\u20139. https:\/\/doi.org\/10.2147\/RRU.S89544.","journal-title":"Res Rep Urol"},{"issue":"12","key":"3658_CR28","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1007\/s00192-020-04429-8","volume":"31","author":"M Wang","year":"2020","unstructured":"Wang M, Jian Z, Ma Y, Jin X, Li H, Wang K. Percutaneous tibial nerve stimulation for overactive bladder syndrome: a systematic review and meta-analysis. Int Urogynecol J. 2020;31(12):2457\u201371. https:\/\/doi.org\/10.1007\/s00192-020-04429-8.","journal-title":"Int Urogynecol J"},{"issue":"1","key":"3658_CR29","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/JU.0000000000000462","volume":"203","author":"B Chughtai","year":"2020","unstructured":"Chughtai B, Clemens JQ, Thomas D, Sun T, Ghomrawi H, Sedrakyan A. Real world performance of sacral neuromodulation and OnabotulinumtoxinA for overactive bladder: focus on safety and cost. J Urol. 2020;203(1):179\u201384. https:\/\/doi.org\/10.1097\/JU.0000000000000462.","journal-title":"J Urol"},{"issue":"1","key":"3658_CR30","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ucl.2004.09.001","volume":"32","author":"A Hijaz","year":"2005","unstructured":"Hijaz A, Vasavada S. Complications and troubleshooting of sacral neuromodulation therapy. Urol Clin North Am. 2005;32(1):65\u20139. https:\/\/doi.org\/10.1016\/j.ucl.2004.09.001.","journal-title":"Urol Clin North Am"},{"issue":"8","key":"3658_CR31","doi-asserted-by":"publisher","first-page":"e196","DOI":"10.1111\/j.1463-1318.2011.02646.x","volume":"13","author":"TC Dudding","year":"2011","unstructured":"Dudding TC, Hollingshead JR, Nicholls RJ, Vaizey CJ. Sacral nerve stimulation for faecal incontinence: optimizing outcome and managing complications: optimizing sacral nerve stimulation. Colorectal Dis. 2011;13(8):e196-202. https:\/\/doi.org\/10.1111\/j.1463-1318.2011.02646.x.","journal-title":"Colorectal Dis"},{"issue":"6","key":"3658_CR32","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1080\/003655900455440","volume":"34","author":"C Edlund","year":"2000","unstructured":"Edlund C, Hellstr\u00f6m M, Peeker R, Fall M. First Scandinavian experience of electrical sacral nerve stimulation in the treatment of the overactive bladder. Scand J Urol Nephrol. 2000;34(6):366\u201376. https:\/\/doi.org\/10.1080\/003655900455440.","journal-title":"Scand J Urol Nephrol"},{"issue":"2","key":"3658_CR33","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/S0022-5347(05)68558-8","volume":"162","author":"RA Schmidt","year":"1999","unstructured":"Schmidt RA, Jonas U, Oleson KA, et al. Sacral nerve stimulation for treatment of refractory urinary urge incontinence. J Urol. 1999;162(2):352\u20137. https:\/\/doi.org\/10.1016\/S0022-5347(05)68558-8.","journal-title":"J Urol"},{"issue":"6","key":"3658_CR34","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0090-4295(00)00597-5","volume":"56","author":"SW Siegel","year":"2000","unstructured":"Siegel SW, Catanzaro F, Dijkema HE, et al. Long-term results of a multicenter study on sacral nerve stimulation for treatment of urinary urge incontinence, urgency-frequency, and retention. Urology. 2000;56(6):87\u201391. https:\/\/doi.org\/10.1016\/S0090-4295(00)00597-5.","journal-title":"Urology"},{"issue":"4","key":"3658_CR35","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1002\/nau.24317","volume":"39","author":"B Blok","year":"2020","unstructured":"Blok B, Van Kerrebroeck P, De Wachter S, et al. Two-year safety and efficacy outcomes for the treatment of overactive bladder using a long-lived rechargeable sacral neuromodulation system. Neurourol Urodyn. 2020;39(4):1108\u201314. https:\/\/doi.org\/10.1002\/nau.24317.","journal-title":"Neurourol Urodyn"},{"issue":"2","key":"3658_CR36","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1002\/nau.24615","volume":"40","author":"A Pezzella","year":"2021","unstructured":"Pezzella A, McCrery R, Lane F, et al. Two-year outcomes of the ARTISAN-SNM study for the treatment of urinary urgency incontinence using the Axonics rechargeable sacral neuromodulation system. Neurourol Urodyn. 2021;40(2):714\u201321. https:\/\/doi.org\/10.1002\/nau.24615.","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"3658_CR37","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/S0090-4295(96)00506-7","volume":"49","author":"RA Janknegt","year":"1997","unstructured":"Janknegt RA, Weil EHJ, Eerdmans PHA. Improving neuromodulation technique for refractory voiding dysfunctions: two-stage implant. Urology. 1997;49(3):358\u201362. https:\/\/doi.org\/10.1016\/S0090-4295(96)00506-7.","journal-title":"Urology"},{"issue":"5","key":"3658_CR38","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1097\/00005392-199805000-00028","volume":"159","author":"HS Shaker","year":"1998","unstructured":"Shaker HS, Hassouna M. Sacral nerve root neuromodulation: an effective treatment for refractory urge incontinence. J Urol. 1998;159(5):1516\u20139. https:\/\/doi.org\/10.1097\/00005392-199805000-00028.","journal-title":"J Urol"},{"issue":"5","key":"3658_CR39","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s003450050074","volume":"16","author":"EHJ Weil","year":"1998","unstructured":"Weil EHJ, Ruiz-Cerd\u00e1 JL, Eerdmans PHA, Janknegt RA, Van Kerrebroeck PEVA. Clinical results of sacral neuromodulation for chronic voiding dysfunction using unilateral sacral foramen electrodes. World J Urol. 1998;16(5):313\u201321. https:\/\/doi.org\/10.1007\/s003450050074.","journal-title":"World J Urol"},{"issue":"2","key":"3658_CR40","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1159\/000020134","volume":"37","author":"EHJ Weil","year":"2000","unstructured":"Weil EHJ, Ruiz-Cerd\u00e1 JL, Eerdmans PHA, Janknegt RA, Bemelmans BLH, Van Kerrebroeck PEV. Sacral root neuromodulation in the treatment of refractory urinary urge incontinence: a prospective randomized clinical trial. Eur Urol. 2000;37(2):161\u201371. https:\/\/doi.org\/10.1159\/000020134.","journal-title":"Eur Urol"},{"issue":"3 Part 1","key":"3658_CR41","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/S0022-5347(01)62795-2","volume":"160","author":"M Hohenfellner","year":"1998","unstructured":"Hohenfellner M, Schultz-Lampel D, Dahms S, Matzel K, Thuroff JW. Bilateral chronic sacral neuromodulation for treatment of lower urinary tract dysfunction. J Urol. 1998;160(3 Part 1):821\u20134. https:\/\/doi.org\/10.1016\/S0022-5347(01)62795-2.","journal-title":"J Urol"},{"issue":"5","key":"3658_CR42","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/S0022-5347(05)68177-3","volume":"162","author":"PM Braun","year":"1999","unstructured":"Braun PM, Boschert J, Bross S, Scheepe JR, Alken P, Juenemann P. Tailored laminectomy: a new technique for neuromodulator implantation. J Urol. 1999;162(5):1607\u20139. https:\/\/doi.org\/10.1016\/S0022-5347(05)68177-3.","journal-title":"J Urol"},{"issue":"4","key":"3658_CR43","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/S0022-5347(05)67728-2","volume":"163","author":"JL Bosch","year":"2000","unstructured":"Bosch JL, Groen J. Sacral nerve neuromodulation in the treatment of patients with refractory motor urge incontinence: long-term results of a prospective longitudinal study. J Urol. 2000;163(4):1219\u201322.","journal-title":"J Urol"},{"issue":"4","key":"3658_CR44","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s001920070031","volume":"11","author":"K Everaert","year":"2000","unstructured":"Everaert K, De Ridder D, Baert L, Oosterlinck W, Wyndaele JJ. Patient satisfaction and complications following sacral nerve stimulation for urinary retention, urge incontinence and perineal pain: a multicenter evaluation. Int Urogynecol J Pelvic Floor Dysfunct. 2000;11(4):231\u20136. https:\/\/doi.org\/10.1007\/s001920070031.","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"issue":"3","key":"3658_CR45","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s11934-000-0019-z","volume":"1","author":"V Gr\u00fcenewald","year":"2000","unstructured":"Gr\u00fcenewald V, Jonas U. Neurostimulation for lower urinary tract voiding problems. Curr Urol Rep. 2000;1(3):199\u2013203. https:\/\/doi.org\/10.1007\/s11934-000-0019-z.","journal-title":"Curr Urol Rep"},{"issue":"1","key":"3658_CR46","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1159\/000052420","volume":"39","author":"RA Janknegt","year":"2001","unstructured":"Janknegt RA, Hassouna MM, Siegel SW, et al. Long-term effectiveness of sacral nerve stimulation for refractory urge incontinence. Eur Urol. 2001;39(1):101\u20136. https:\/\/doi.org\/10.1159\/000052420.","journal-title":"Eur Urol"},{"issue":"6","key":"3658_CR47","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1016\/S0022-5347(05)65550-4","volume":"166","author":"F Cappellano","year":"2001","unstructured":"Cappellano F, Bertapelle P, Spinelli M, et al. Quality of life assessment in patients who undergo sacral neuromodulation implantation for urge incontinence: an additional tool for evaluating outcome. J Urol. 2001;166(6):2277\u201380.","journal-title":"J Urol"},{"issue":"4","key":"3658_CR48","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1159\/000049812","volume":"40","author":"WA Scheepens","year":"2001","unstructured":"Scheepens WA, Weil EHJ, Van Koeveringe GA, et al. Buttock placement of the implantable pulse generator: a new implantation technique for sacral neuromodulation\u2014a multicenter study. Eur Urol. 2001;40(4):434\u20138. https:\/\/doi.org\/10.1159\/000049812.","journal-title":"Eur Urol"},{"issue":"4","key":"3658_CR49","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1080\/003655902320766024","volume":"36","author":"H Hedlund","year":"2002","unstructured":"Hedlund H, Schultz A, Talseth T, Tonseth K, Hagen AVD. Sacral neuromodulation in Norway: clinical experience of the first three years. Scand J Urol Nephrol. 2002;36(4):87\u201394. https:\/\/doi.org\/10.1080\/003655902320766024.","journal-title":"Scand J Urol Nephrol"},{"issue":"1","key":"3658_CR50","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S0090-4295(02)01630-8","volume":"60","author":"S Aboseif","year":"2002","unstructured":"Aboseif S, Tamaddon K, Chalfin S, Freedman S, Kaptein J. Sacral neuromodulation as an effective treatment for refractory pelvic floor dysfunction. Urology. 2002;60(1):52\u20136. https:\/\/doi.org\/10.1016\/S0090-4295(02)01630-8.","journal-title":"Urology"},{"issue":"6","key":"3658_CR51","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1067\/mob.2002.130004","volume":"187","author":"CL Amundsen","year":"2002","unstructured":"Amundsen CL, Webster GD. Sacral neuromodulation in an older, urge-incontinent population. Am J Obstet Gynecol. 2002;187(6):1462\u20135. https:\/\/doi.org\/10.1067\/mob.2002.130004.","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"3658_CR52","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1046\/j.1464-410X.2002.03028.x","volume":"90","author":"WA Scheepens","year":"2002","unstructured":"Scheepens WA, Van Koeveringe GA, De Bie RA, Weil EHJ, Van Kerrebroeck PHEV. Long-term efficacy and safety results of the two-stage implantation technique in sacral neuromodulation. BJU Int. 2002;90(9):840\u20135. https:\/\/doi.org\/10.1046\/j.1464-410X.2002.03028.x.","journal-title":"BJU Int"},{"issue":"1","key":"3658_CR53","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/S0302-2838(02)00442-6","volume":"43","author":"M Spinelli","year":"2003","unstructured":"Spinelli M, Giardiello G, Arduini A, Van Den Hombergh U. New percutaneous technique of sacral nerve stimulation has high initial success rate: preliminary results. Eur Urol. 2003;43(1):70\u20134. https:\/\/doi.org\/10.1016\/S0302-2838(02)00442-6.","journal-title":"Eur Urol"},{"issue":"4","key":"3658_CR54","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.urology.2005.04.031","volume":"66","author":"CL Amundsen","year":"2005","unstructured":"Amundsen CL, Romero AA, Jamison MG, Webster GD. Sacral neuromodulation for intractable urge incontinence: are there factors associated with cure? Urology. 2005;66(4):746\u201350. https:\/\/doi.org\/10.1016\/j.urology.2005.04.031.","journal-title":"Urology"},{"issue":"3","key":"3658_CR55","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00345-005-0502-8","volume":"23","author":"M Spinelli","year":"2005","unstructured":"Spinelli M, Weil E, Ostardo E, et al. New tined lead electrode in sacral neuromodulation: experience from a multicentre European study. World J Urol. 2005;23(3):225\u20139. https:\/\/doi.org\/10.1007\/s00345-005-0502-8.","journal-title":"World J Urol"},{"issue":"5","key":"3658_CR56","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1016\/j.juro.2007.07.032","volume":"178","author":"PEV Van Kerrebroeck","year":"2007","unstructured":"Van Kerrebroeck PEV, Van Voskuilen AC, Heesakkers JPFA, et al. Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J Urol. 2007;178(5):2029\u201334. https:\/\/doi.org\/10.1016\/j.juro.2007.07.032.","journal-title":"J Urol"},{"issue":"2","key":"3658_CR57","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/nau.20330","volume":"26","author":"RT Foster","year":"2007","unstructured":"Foster RT, Anoia EJ, Webster GD, Amundsen CL. In patients undergoing neuromodulation for intractable urge incontinence a reduction in 24-hr pad weight after the initial test stimulation best predicts long-term patient satisfaction. Neurourol Urodyn. 2007;26(2):213\u20137. https:\/\/doi.org\/10.1002\/nau.20330.","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"3658_CR58","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1464-410X.2006.06508.x","volume":"99","author":"AC Van Voskuilen","year":"2007","unstructured":"Van Voskuilen AC, Oerlemans DJAJ, Weil EHJ, Van Den Hombergh U, Van Kerrebroeck PEVA. Medium-term experience of sacral neuromodulation by tined lead implantation. BJU Int. 2007;99(1):107\u201310. https:\/\/doi.org\/10.1111\/j.1464-410X.2006.06508.x.","journal-title":"BJU Int"},{"issue":"1","key":"3658_CR59","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/nau.20332","volume":"26","author":"KM Borawski","year":"2007","unstructured":"Borawski KM, Foster RT, Webster GD, Amundsen CL. Predicting implantation with a neuromodulator using two different test stimulation techniques: a prospective randomized study in urge incontinent women. Neurourol Urodyn. 2007;26(1):14\u20138. https:\/\/doi.org\/10.1002\/nau.20332.","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"3658_CR60","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/nau.20345","volume":"26","author":"SE Sutherland","year":"2007","unstructured":"Sutherland SE, Lavers A, Carlson A, Holtz C, Kesha J, Siegel SW. Sacral nerve stimulation for voiding dysfunction: one institution\u2019s 11-year experience. Neurourol Urodyn. 2007;26(1):19\u201328. https:\/\/doi.org\/10.1002\/nau.20345.","journal-title":"Neurourol Urodyn"},{"issue":"9","key":"3658_CR61","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/j.1464-410X.2007.07426.x","volume":"101","author":"RE Blandon","year":"2008","unstructured":"Blandon RE, Gebhart JB, Lightner DJ, Klingele CJ. Re-operation rates after permanent sacral nerve stimulation for refractory voiding dysfunction in women. BJU Int. 2008;101(9):1119\u201323. https:\/\/doi.org\/10.1111\/j.1464-410X.2007.07426.x.","journal-title":"BJU Int"},{"issue":"3","key":"3658_CR62","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.juro.2011.04.059","volume":"186","author":"J Groen","year":"2011","unstructured":"Groen J, Blok BFM, Bosch JLHR. Sacral neuromodulation as treatment for refractory idiopathic urge urinary incontinence: 5-year results of a longitudinal study in 60 women. J Urol. 2011;186(3):954\u20139. https:\/\/doi.org\/10.1016\/j.juro.2011.04.059.","journal-title":"J Urol"},{"issue":"3","key":"3658_CR63","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/luts.12036","volume":"6","author":"KH Moon","year":"2014","unstructured":"Moon KH, Han JY, Kim JH, et al. Prospective trial of sacral neuromodulation for refractory overactive bladder syndrome in Korean patients. LUTS. 2014;6(3):175\u20139. https:\/\/doi.org\/10.1111\/luts.12036.","journal-title":"LUTS"},{"issue":"5","key":"3658_CR64","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1111\/bju.12571","volume":"113","author":"K Peeters","year":"2014","unstructured":"Peeters K, Sahai A, De Ridder D, Van Der Aa F. Long-term follow-up of sacral neuromodulation for lower urinary tract dysfunction. BJU Int. 2014;113(5):789\u201394. https:\/\/doi.org\/10.1111\/bju.12571.","journal-title":"BJU Int"},{"issue":"8","key":"3658_CR65","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/ner.12696","volume":"20","author":"S Ismail","year":"2017","unstructured":"Ismail S, Chartier-Kastler E, Perrouin-Verbe MA, Rose-Dite-Modestine J, Denys P, Ph\u00e9 V. Long-term functional outcomes of S3 sacral neuromodulation for the treatment of idiopathic overactive bladder. Neuromodulation. 2017;20(8):825\u20139. https:\/\/doi.org\/10.1111\/ner.12696.","journal-title":"Neuromodulation"},{"issue":"4","key":"3658_CR66","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/SPV.0000000000000457","volume":"24","author":"S Siegel","year":"2018","unstructured":"Siegel S, Kreder K, Takacs E, McNamara R, Kan F. Prospective randomized feasibility study assessing the effect of cyclic sacral neuromodulation on urinary urge incontinence in women. Female Pelvic Med Reconstr Surg. 2018;24(4):267\u201371. https:\/\/doi.org\/10.1097\/SPV.0000000000000457.","journal-title":"Female Pelvic Med Reconstr Surg"},{"issue":"1","key":"3658_CR67","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.eururo.2018.02.011","volume":"74","author":"CL Amundsen","year":"2018","unstructured":"Amundsen CL, Komesu YM, Chermansky C, et al. Two-year outcomes of sacral neuromodulation versus OnabotulinumtoxinA for refractory urgency urinary incontinence: a randomized trial. Eur Urol. 2018;74(1):66\u201373. https:\/\/doi.org\/10.1016\/j.eururo.2018.02.011.","journal-title":"Eur Urol"},{"issue":"6","key":"3658_CR68","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/ner.12902","volume":"22","author":"P Zhang","year":"2019","unstructured":"Zhang P, Wang JY, Zhang Y, et al. Results of sacral neuromodulation therapy for urinary voiding dysfunction: five-year experience of a retrospective, multicenter study in China. Neuromodulation. 2019;22(6):730\u20137. https:\/\/doi.org\/10.1111\/ner.12902.","journal-title":"Neuromodulation"},{"issue":"2","key":"3658_CR69","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1080\/2090598X.2020.1740391","volume":"18","author":"IS Al Azzawi","year":"2020","unstructured":"Al Azzawi IS, Al Hindawi HT. A comparative study between sacral neuromodulation and intravesical botulinum toxin injection for patients with refractory overactive bladder. Arab J Urol. 2020;18(2):88\u201393. https:\/\/doi.org\/10.1080\/2090598X.2020.1740391.","journal-title":"Arab J Urol"},{"issue":"7","key":"3658_CR70","doi-asserted-by":"publisher","first-page":"e0235961","DOI":"10.1371\/journal.pone.0235961","volume":"15","author":"B Kaaki","year":"2020","unstructured":"Kaaki B, Gupta D. Medium-term outcomes of sacral neuromodulation in patients with refractory overactive bladder: a retrospective single-institution study. PLoS ONE. 2020;15(7):e0235961. https:\/\/doi.org\/10.1371\/journal.pone.0235961.","journal-title":"PLoS ONE"},{"issue":"5","key":"3658_CR71","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.21037\/tau-21-43","volume":"10","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Meng L, Zhang P, et al. Intermediate-term results of a prospective, multicenter study on remote programming sacral neuromodulation for refractory overactive bladder. Transl Androl Urol. 2021;10(5):1966\u201375. https:\/\/doi.org\/10.21037\/tau-21-43.","journal-title":"Transl Androl Urol"},{"issue":"6","key":"3658_CR72","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.euf.2022.04.006","volume":"8","author":"L Liao","year":"2022","unstructured":"Liao L, Zhou Z, Chen G, et al. Sacral neuromodulation using a novel device with a six\u2013contact-point electrode for the treatment of patients with refractory overactive bladder: a multicenter, randomized, single-blind, parallel-control clinical trial. Eur Urol Focus. 2022;8(6):1823\u201330. https:\/\/doi.org\/10.1016\/j.euf.2022.04.006.","journal-title":"Eur Urol Focus"},{"issue":"1","key":"3658_CR73","doi-asserted-by":"publisher","first-page":"22299","DOI":"10.1038\/s41598-022-26267-y","volume":"12","author":"L Meng","year":"2022","unstructured":"Meng L, Tian Z, Zhang Y, et al. Sacral neuromodulation for overactive bladder using the InterStim and BetterStim systems. Sci Rep. 2022;12(1):22299. https:\/\/doi.org\/10.1038\/s41598-022-26267-y.","journal-title":"Sci Rep"},{"issue":"5","key":"3658_CR74","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.euf.2023.03.008","volume":"9","author":"E Chartier-Kastler","year":"2023","unstructured":"Chartier-Kastler E, Le Normand L, Ruffion A, et al. Five-year results from the prospective, multicenter, observational SOUNDS study of patients with overactive bladder treated with the InterStim system for sacral neuromodulation. Eur Urol Focus. 2023;9(5):765\u201372. https:\/\/doi.org\/10.1016\/j.euf.2023.03.008.","journal-title":"Eur Urol Focus"},{"issue":"4","key":"3658_CR75","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1002\/nau.25171","volume":"42","author":"C Goudelocke","year":"2023","unstructured":"Goudelocke C, Xavier K, Pecha B, et al. Evaluation of clinical performance and safety for the rechargeable InterStim micro device in overactive bladder subjects: 6-month results from the global postmarket ELITE study. Neurourol Urodyn. 2023;42(4):761\u20139. https:\/\/doi.org\/10.1002\/nau.25171.","journal-title":"Neurourol Urodyn"},{"issue":"8","key":"3658_CR76","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1002\/nau.25562","volume":"43","author":"WK Hendrickson","year":"2024","unstructured":"Hendrickson WK, Zhang C, Hokanson JA, Nygaard IE, Presson AP. Predicting success using response after lead implantation with sacral neuromodulation for urgency incontinence. Neurourol Urodyn. 2024;43(8):1776\u201383. https:\/\/doi.org\/10.1002\/nau.25562.","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"3658_CR77","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1097\/SPV.0000000000001635","volume":"31","author":"H Query","year":"2025","unstructured":"Query H, Morgan T, Klausner AP, Burkett LS. Sacral neuromodulation reprogramming rates: understanding office-based requirement. Urogynecology. 2025;31(4):444\u20138. https:\/\/doi.org\/10.1097\/SPV.0000000000001635.","journal-title":"Urogynecology"},{"issue":"4","key":"3658_CR78","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1179\/1079026814Z.000000000273","volume":"38","author":"Y Liu","year":"2015","unstructured":"Liu Y, Zhou X, Ma J, Ge Y, Cao X. The diameters and number of nerve fibers in spinal nerve roots. J Spinal Cord Med. 2015;38(4):532\u20137. https:\/\/doi.org\/10.1179\/1079026814Z.000000000273.","journal-title":"J Spinal Cord Med"},{"issue":"1","key":"3658_CR79","first-page":"123","volume":"11","author":"G Schalow","year":"1992","unstructured":"Schalow G. Ventral root afferent and dorsal root efferent fibres in dog and human lower sacral nerve roots. Gen Physiol Biophys. 1992;11(1):123\u201331.","journal-title":"Gen Physiol Biophys"},{"issue":"3","key":"3658_CR80","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3171\/2009.3.SPINE17684","volume":"11","author":"EF Hauck","year":"2009","unstructured":"Hauck EF, Schwefer M, Wittkowski W, Bothe HW. Measurements and mapping of 282,420 nerve fibers in the S1\u20135 nerve roots: laboratory investigation. J Neurosurg Spine. 2009;11(3):255\u201363. https:\/\/doi.org\/10.3171\/2009.3.SPINE17684.","journal-title":"J Neurosurg Spine"},{"issue":"1","key":"3658_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5812\/ipmn.116625","volume":"1","author":"M Hashemi","year":"2021","unstructured":"Hashemi M, Momenzadeh S, Taheri M, Rajaei S. The importance of sacral neuroanatomy in pain syndromes and procedures. Interv Pain Med Neuromodul. 2021;1(1):1. https:\/\/doi.org\/10.5812\/ipmn.116625.","journal-title":"Interv Pain Med Neuromodul"},{"issue":"1","key":"3658_CR82","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1515\/tnsci-2020-0184","volume":"12","author":"I Alkatout","year":"2021","unstructured":"Alkatout I, Wedel T, Pape J, Possover M, Dhanawat J. Review: pelvic nerves\u2014from anatomy and physiology to clinical applications. Transl Neurosci. 2021;12(1):362\u201378. https:\/\/doi.org\/10.1515\/tnsci-2020-0184.","journal-title":"Transl Neurosci"},{"issue":"1","key":"3658_CR83","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/ar.1090740110","volume":"74","author":"MT Horwitz","year":"1939","unstructured":"Horwitz MT. The anatomy of (A) the lumbosacral nerve plexus\u2014its relation to variations of vertebral segmentation, and (B), the posterior sacral nerve plexus. Anat Rec. 1939;74(1):91\u2013107. https:\/\/doi.org\/10.1002\/ar.1090740110.","journal-title":"Anat Rec"},{"issue":"5","key":"3658_CR84","doi-asserted-by":"publisher","first-page":"727.e1","DOI":"10.1016\/j.ajog.2015.06.009","volume":"213","author":"PA Maldonado","year":"2015","unstructured":"Maldonado PA, Chin K, Garcia AA, Corton MM. Anatomic variations of pudendal nerve within pelvis and pudendal canal: clinical applications. Am J Obstet Gynecol. 2015;213(5):727.e1-727.e6. https:\/\/doi.org\/10.1016\/j.ajog.2015.06.009.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"3658_CR85","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00276-009-0546-3","volume":"32","author":"V Matej\u010d\u00edk","year":"2010","unstructured":"Matej\u010d\u00edk V. Anatomical variations of lumbosacral plexus. Surg Radiol Anat. 2010;32(4):409\u201314. https:\/\/doi.org\/10.1007\/s00276-009-0546-3.","journal-title":"Surg Radiol Anat"},{"issue":"2","key":"3658_CR86","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0022-5347(17)36078-0","volume":"149","author":"A Mersdorf","year":"1993","unstructured":"Mersdorf A, Schmidt RA, Tanagho EA. Topographic-anatomical basis of sacral neurostimulation: neuroanatomical variations. J Urol. 1993;149(2):345\u20139. https:\/\/doi.org\/10.1016\/S0022-5347(17)36078-0.","journal-title":"J Urol"},{"issue":"4","key":"3658_CR87","doi-asserted-by":"publisher","first-page":"388.e1","DOI":"10.1016\/j.ajog.2016.12.002","volume":"216","author":"CM Ripperda","year":"2017","unstructured":"Ripperda CM, Jackson LA, Phelan JN, Carrick KS, Corton MM. Anatomic relationships of the pelvic autonomic nervous system in female cadavers: clinical applications to pelvic surgery. Am J Obstet Gynecol. 2017;216(4):388.e1-388.e7. https:\/\/doi.org\/10.1016\/j.ajog.2016.12.002.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"3658_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/nrn2401","volume":"9","author":"CJ Fowler","year":"2008","unstructured":"Fowler CJ, Griffiths D, De Groat WC. The neural control of micturition. Nat Rev Neurosci. 2008;9(6):6. https:\/\/doi.org\/10.1038\/nrn2401.","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"3658_CR89","doi-asserted-by":"publisher","first-page":"961","DOI":"10.3171\/2014.9.SPINE13667","volume":"21","author":"L Carlucci","year":"2014","unstructured":"Carlucci L, Wavasseur T, B\u00e9nard A, et al. Functional variability of sacral roots in bladder control: clinical article. J Neurosurg Spine. 2014;21(6):961\u20135. https:\/\/doi.org\/10.3171\/2014.9.SPINE13667.","journal-title":"J Neurosurg Spine"},{"key":"3658_CR90","doi-asserted-by":"publisher","unstructured":"Juenemann KP, Lue TF, Schmidt RA, Tanagho EA. Clinical significance of sacral and pudendal nerve anatomy. J Urol. 1988;139(1):74\u201380. https:\/\/doi.org\/10.1016\/S0022-5347(17)42297-X.","DOI":"10.1016\/S0022-5347(17)42297-X"},{"key":"3658_CR91","first-page":"245","volume-title":"Surgical anatomy of the sacral plexus and its branches","author":"RS Tubbs","year":"2021","unstructured":"Tubbs RS, Iwanaga J, Loukas M, Dumont AS, Reina MA. Surgical anatomy of the sacral plexus and its branches. St. Louis, Missouri: Elsevier; 2021. p. 245."},{"issue":"5","key":"3658_CR92","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.euf.2019.11.018","volume":"6","author":"S De Wachter","year":"2020","unstructured":"De Wachter S, Vaganee D, Kessler TM. Sacral neuromodulation: mechanism of action. Eur Urol Focus. 2020;6(5):823\u20135. https:\/\/doi.org\/10.1016\/j.euf.2019.11.018.","journal-title":"Eur Urol Focus"},{"issue":"12","key":"3658_CR93","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/ncpuro1251","volume":"5","author":"TM Kessler","year":"2008","unstructured":"Kessler TM, Fowler CJ. Sacral neuromodulation for urinary retention. Nat Clin Pract Urol. 2008;5(12):657\u201366. https:\/\/doi.org\/10.1038\/ncpuro1251.","journal-title":"Nat Clin Pract Urol"},{"issue":"1","key":"3658_CR94","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ucl.2004.09.004","volume":"32","author":"WW Leng","year":"2005","unstructured":"Leng WW, Chancellor MB. How sacral nerve stimulation neuromodulation works. Urol Clin North Am. 2005;32(1):11\u20138. https:\/\/doi.org\/10.1016\/j.ucl.2004.09.004.","journal-title":"Urol Clin North Am"},{"issue":"6","key":"3658_CR95","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1111\/j.1464-410X.2005.05734.x","volume":"96","author":"SH Riazimand","year":"2005","unstructured":"Riazimand SH, Mense S. Interaction between neurotransmitter antagonists and effects of sacral neuromodulation in rats with chronically hyperactive bladder. BJU Int. 2005;96(6):900\u20138. https:\/\/doi.org\/10.1111\/j.1464-410X.2005.05734.x.","journal-title":"BJU Int"},{"issue":"4","key":"3658_CR96","doi-asserted-by":"publisher","first-page":"F543","DOI":"10.1152\/ajprenal.00373.2017","volume":"314","author":"JA Hokanson","year":"2018","unstructured":"Hokanson JA, Langdale CL, Sridhar A, Grill WM. Stimulation of the sensory pudendal nerve increases bladder capacity in the rat. Am J Physiol Renal Physiol. 2018;314(4):F543\u201350. https:\/\/doi.org\/10.1152\/ajprenal.00373.2017.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"8","key":"3658_CR97","doi-asserted-by":"publisher","first-page":"F921","DOI":"10.1152\/ajprenal.00330.2014","volume":"307","author":"MJ McGee","year":"2014","unstructured":"McGee MJ, Danziger ZC, Bamford JA, Grill WM. A spinal GABAergic mechanism is necessary for bladder inhibition by pudendal afferent stimulation. Am J Physiol Renal Physiol. 2014;307(8):F921\u201330. https:\/\/doi.org\/10.1152\/ajprenal.00330.2014.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"3658_CR98","doi-asserted-by":"publisher","first-page":"F757","DOI":"10.1152\/ajprenal.00123.2023","volume":"325","author":"JA Hokanson","year":"2023","unstructured":"Hokanson JA, Langdale CL, Grill WM. Pathways and parameters of sacral neuromodulation in rats. Am J Physiol Renal Physiol. 2023;325(6):F757\u201369. https:\/\/doi.org\/10.1152\/ajprenal.00123.2023.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"5","key":"3658_CR99","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1002\/nau.24408","volume":"39","author":"D Vagan\u00e9e","year":"2020","unstructured":"Vagan\u00e9e D, Voorham J, Panicker JN, et al. Neural pathway of bellows response during SNM treatment revisited: conclusive evidence for direct efferent motor response. Neurourol Urodyn. 2020;39(5):1576\u201383. https:\/\/doi.org\/10.1002\/nau.24408.","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"3658_CR100","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1540\/jsmr.41.117","volume":"41","author":"K Sugaya","year":"2005","unstructured":"Sugaya K, Nishijima S, Miyazato M, Ogawa Y. Central nervous control of micturition and urine storage. J Smooth Muscle Res. 2005;41(3):117\u201332. https:\/\/doi.org\/10.1540\/jsmr.41.117.","journal-title":"J Smooth Muscle Res"},{"issue":"3","key":"3658_CR101","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1590\/s1677-5538.ibju.2021.99.08","volume":"47","author":"M Mass-Lindenbaum","year":"2021","unstructured":"Mass-Lindenbaum M, Calder\u00f3n-Pollak D, Goldman HB, Pizarro-Berdichevsky J. Sacral neuromodulation\u2014when and for who. Int Braz J Urol. 2021;47(3):647\u201356. https:\/\/doi.org\/10.1590\/s1677-5538.ibju.2021.99.08.","journal-title":"Int Braz J Urol"},{"issue":"5","key":"3658_CR102","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/S0302-2838(02)00029-5","volume":"41","author":"PM Braun","year":"2002","unstructured":"Braun PM, Baezner H, Seif C, et al. Alterations of cortical electrical activity in patients with sacral neuromodulator. Eur Urol. 2002;41(5):562\u20137. https:\/\/doi.org\/10.1016\/S0302-2838(02)00029-5.","journal-title":"Eur Urol"},{"issue":"6","key":"3658_CR103","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1111\/j.1464-410X.2006.06521.x","volume":"98","author":"BFM Blok","year":"2006","unstructured":"Blok BFM, Groen J, Bosch JLHR, Veltman DJ, Lammertsma AA. Different brain effects during chronic and acute sacral neuromodulation in urge incontinent patients with implanted neurostimulators. BJU Int. 2006;98(6):1238\u201343. https:\/\/doi.org\/10.1111\/j.1464-410X.2006.06521.x.","journal-title":"BJU Int"},{"issue":"6","key":"3658_CR104","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.juro.2017.06.074","volume":"198","author":"BC Gill","year":"2017","unstructured":"Gill BC, Pizarro-Berdichevsky J, Bhattacharyya PK, et al. Real-time changes in brain activity during sacral neuromodulation for overactive bladder. J Urol. 2017;198(6):1379\u201385. https:\/\/doi.org\/10.1016\/j.juro.2017.06.074.","journal-title":"J Urol"},{"issue":"6","key":"3658_CR105","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1097\/JU.0000000000002445","volume":"207","author":"D Pang","year":"2022","unstructured":"Pang D, Liao L, Chen G, Wang Y. Sacral neuromodulation improves abnormal prefrontal brain activity in patients with overactive bladder: a possible central mechanism. J Urol. 2022;207(6):1256\u201367. https:\/\/doi.org\/10.1097\/JU.0000000000002445.","journal-title":"J Urol"},{"issue":"2","key":"3658_CR106","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.juro.2018.03.129","volume":"200","author":"SJ Weissbart","year":"2018","unstructured":"Weissbart SJ, Bhavsar R, Rao H, et al. Specific changes in brain activity during urgency in women with overactive bladder after successful sacral neuromodulation: a functional magnetic resonance imaging study. J Urol. 2018;200(2):382\u20138. https:\/\/doi.org\/10.1016\/j.juro.2018.03.129.","journal-title":"J Urol"},{"issue":"9","key":"3658_CR107","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1007\/s00192-020-04615-8","volume":"32","author":"WK Hendrickson","year":"2021","unstructured":"Hendrickson WK, Amundsen CL. Sacral neuromodulation: sacral anatomy and optimal lead placement. Int Urogynecol J Pelvic Floor Dysfunct. 2021;32(9):2545\u20137. https:\/\/doi.org\/10.1007\/s00192-020-04615-8.","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"issue":"5","key":"3658_CR108","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.neurom.2024.08.001","volume":"28","author":"S Tilborghs","year":"2025","unstructured":"Tilborghs S, Brits T, Van De Borne S, Vagan\u00e9e D, De Wachter S. Motor response matters: lead placement and urologic efficacy linked in sacral neuromodulation. Neuromodulation. 2025;28(5):865\u201372. https:\/\/doi.org\/10.1016\/j.neurom.2024.08.001.","journal-title":"Neuromodulation"},{"issue":"5","key":"3658_CR109","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1002\/nau.23515","volume":"37","author":"HB Goldman","year":"2018","unstructured":"Goldman HB, Lloyd JC, Noblett KL, et al. International Continence Society best practice statement for use of sacral neuromodulation. Neurourol Urodyn. 2018;37(5):1823\u201348. https:\/\/doi.org\/10.1002\/nau.23515.","journal-title":"Neurourol Urodyn"},{"issue":"6","key":"3658_CR110","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/SPV.0b013e3182a2954e","volume":"19","author":"J Lee","year":"2013","unstructured":"Lee J, Osann K, Noblett K. Comparison of motor and sensory response of InterStim\u00ae for overactive bladder syndrome. Female Pelvic Med Reconstr Surg. 2013;19(6):317\u201321. https:\/\/doi.org\/10.1097\/SPV.0b013e3182a2954e.","journal-title":"Female Pelvic Med Reconstr Surg"},{"issue":"3","key":"3658_CR111","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/nau.25393","volume":"43","author":"BT Waldoch","year":"2024","unstructured":"Waldoch BT, Anderson DJ, Narveson SA, O\u2019Connor RC, Guralnick ML. Does choice of anesthesia during stage\u00a01 sacral neuromodulation testing influence outcomes? Neurourol Urodyn. 2024;43(3):574\u20138. https:\/\/doi.org\/10.1002\/nau.25393.","journal-title":"Neurourol Urodyn"},{"issue":"5","key":"3658_CR112","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.neurom.2024.09.477","volume":"28","author":"S Tilborghs","year":"2025","unstructured":"Tilborghs S, Van De Borne S, Vagan\u00e9e D, Fransen E, De Wachter S. A deep analysis of the pelvic floor motor response in sacral neuromodulation linking it to outcome. Neuromodulation. 2025;28(5):787\u201395. https:\/\/doi.org\/10.1016\/j.neurom.2024.09.477.","journal-title":"Neuromodulation"},{"issue":"8","key":"3658_CR113","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1111\/ner.12649","volume":"20","author":"R Jairam","year":"2017","unstructured":"Jairam R, Marcelissen T, Van Koeveringe G, Van Kerrebroeck P. Optimal lead positioning in sacral neuromodulation: which factors are related to treatment outcome? Neuromodulation. 2017;20(8):830\u20135. https:\/\/doi.org\/10.1111\/ner.12649.","journal-title":"Neuromodulation"},{"issue":"6","key":"3658_CR114","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/ner.12953","volume":"22","author":"D Vagan\u00e9e","year":"2019","unstructured":"Vagan\u00e9e D, Voorham J, Voorham-van Der Zalm P, De Wachter S. Needle placement and position of electrical stimulation inside sacral foramen determines pelvic floor electromyographic response\u2014implications for sacral neuromodulation. Neuromodulation. 2019;22(6):709\u201315. https:\/\/doi.org\/10.1111\/ner.12953.","journal-title":"Neuromodulation"},{"issue":"1","key":"3658_CR115","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12894-025-01724-8","volume":"25","author":"T He","year":"2025","unstructured":"He T, Hornung C, Evans MD, et al. A prospective feasibility study to differentiate sacral neuromodulation lead electrode configurations using motor and sensory thresholds and locations of sensation. BMC Urol. 2025;25(1):79\u201386. https:\/\/doi.org\/10.1186\/s12894-025-01724-8.","journal-title":"BMC Urol"},{"issue":"5","key":"3658_CR116","doi-asserted-by":"publisher","first-page":"e1011184","DOI":"10.1371\/journal.pcbi.1011184","volume":"19","author":"F Ciotti","year":"2023","unstructured":"Ciotti F, Cimolato A, Valle G, Raspopovic S. Design of an adaptable intrafascicular electrode (AIR) for selective nerve stimulation by model-based optimization. PLoS Comput Biol. 2023;19(5):e1011184. https:\/\/doi.org\/10.1371\/journal.pcbi.1011184.","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"3658_CR117","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.brs.2007.08.004","volume":"1","author":"CR Butson","year":"2008","unstructured":"Butson CR, McIntyre CC. Current steering to control the volume of tissue activated during deep brain stimulation. Brain Stimul. 2008;1(1):7\u201315. https:\/\/doi.org\/10.1016\/j.brs.2007.08.004.","journal-title":"Brain Stimul"},{"issue":"2","key":"3658_CR118","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s12325-019-01205-z","volume":"37","author":"S De Wachter","year":"2020","unstructured":"De Wachter S, Knowles CH, Elterman DS, et al. New technologies and applications in sacral neuromodulation: an update. Adv Ther. 2020;37(2):637\u201343. https:\/\/doi.org\/10.1007\/s12325-019-01205-z.","journal-title":"Adv Ther"},{"issue":"8","key":"3658_CR119","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s00192-008-0601-3","volume":"19","author":"FN Burks","year":"2008","unstructured":"Burks FN, Diokno AC, Lajiness MJ, Ibrahim IA, Peters KM. Sacral neuromodulation reprogramming: is it an office burden? Int Urogynecol J. 2008;19(8):1137\u201340. https:\/\/doi.org\/10.1007\/s00192-008-0601-3.","journal-title":"Int Urogynecol J"},{"issue":"8","key":"3658_CR120","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.neurom.2021.09.001","volume":"25","author":"S Tilborghs","year":"2022","unstructured":"Tilborghs S, Van De Borne S, Vagan\u00e9e D, De Win G, De Wachter S. The influence of electrode configuration changes on the sensory and motor response during (re)programming in sacral neuromodulation. Neuromodulation. 2022;25(8):1173\u20139. https:\/\/doi.org\/10.1016\/j.neurom.2021.09.001.","journal-title":"Neuromodulation"},{"issue":"8","key":"3658_CR121","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/ner.12710","volume":"20","author":"X Su","year":"2017","unstructured":"Su X, Cutinella M, Agran JE, Dinsmoor DA. Comparison of active stimulating electrodes of sacral neuromodulation. Neuromodulation. 2017;20(8):799\u2013806. https:\/\/doi.org\/10.1111\/ner.12710.","journal-title":"Neuromodulation"},{"issue":"5","key":"3658_CR122","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1016\/j.juro.2010.12.089","volume":"185","author":"TAT Marcelissen","year":"2011","unstructured":"Marcelissen TAT, Leong RK, Nieman FHM, De Bie RA, Van Kerrebroeck PEV, De Wachter SGG. The effect of pulse rate changes on the clinical outcome of sacral neuromodulation. J Urol. 2011;185(5):1781\u20135. https:\/\/doi.org\/10.1016\/j.juro.2010.12.089.","journal-title":"J Urol"},{"issue":"4","key":"3658_CR123","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1002\/nau.25161","volume":"42","author":"J Rueb","year":"2023","unstructured":"Rueb J, Goldman HB, Vasavada S, Moore C, Rackley R, Gill BC. Effect of pulse width variations on sacral neuromodulation for overactive bladder symptoms: a prospective randomized crossover feasibility study. Neurourol Urodyn. 2023;42(4):770\u20137. https:\/\/doi.org\/10.1002\/nau.25161.","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"3658_CR124","doi-asserted-by":"publisher","first-page":"227","DOI":"10.5213\/inj.2244084.042","volume":"26","author":"CM Hornung","year":"2022","unstructured":"Hornung CM, Vasdev R, Hanson KA, et al. Data gap in sacral neuromodulation documentation: call to improve documentation protocols. Int Neurourol J. 2022;26(3):227\u201333. https:\/\/doi.org\/10.5213\/inj.2244084.042.","journal-title":"Int Neurourol J"},{"issue":"1","key":"3658_CR125","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/JU.0000000000003746","volume":"211","author":"WK Hendrickson","year":"2024","unstructured":"Hendrickson WK, Zhang C, Jelovsek JE, Nygaard IE, Presson AP. Longitudinal fluctuations in treatment response after OnabotulinumToxinA and sacral neuromodulation for refractory urgency incontinence. J Urol. 2024;211(1):134\u201343. https:\/\/doi.org\/10.1097\/JU.0000000000003746.","journal-title":"J Urol"},{"issue":"6","key":"3658_CR126","doi-asserted-by":"publisher","first-page":"e0268547","DOI":"10.1371\/journal.pone.0268547","volume":"17","author":"VP Andreev","year":"2022","unstructured":"Andreev VP, Helmuth ME, Liu G, et al. Subtyping of common complex diseases and disorders by integrating heterogeneous data. Identifying clusters among women with lower urinary tract symptoms in the LURN study. PLoS ONE. 2022;17(6):e0268547. https:\/\/doi.org\/10.1371\/journal.pone.0268547.","journal-title":"PLoS ONE"},{"issue":"2","key":"3658_CR127","doi-asserted-by":"publisher","first-page":"026032","DOI":"10.1088\/1741-2552\/acc42b","volume":"20","author":"CJ Davis","year":"2023","unstructured":"Davis CJ, Musselman ED, Grill WM, Pelot NA. Fibers in smaller fascicles have lower activation thresholds with cuff electrodes due to thinner perineurium and smaller cross-sectional area. J Neural Eng. 2023;20(2):026032. https:\/\/doi.org\/10.1088\/1741-2552\/acc42b.","journal-title":"J Neural Eng"},{"issue":"3","key":"3658_CR128","doi-asserted-by":"publisher","first-page":"036032","DOI":"10.1088\/1741-2552\/acda64","volume":"20","author":"ED Musselman","year":"2023","unstructured":"Musselman ED, Pelot NA, Grill WM. Validated computational models predict vagus nerve stimulation thresholds in preclinical animals and humans. J Neural Eng. 2023;20(3):036032. https:\/\/doi.org\/10.1088\/1741-2552\/acda64.","journal-title":"J Neural Eng"},{"issue":"371","key":"3658_CR129","doi-asserted-by":"publisher","first-page":"eaah3532","DOI":"10.1126\/scitranslmed.aah3532","volume":"9","author":"DT Brocker","year":"2017","unstructured":"Brocker DT, Swan BD, So RQ, Turner DA, Gross RE, Grill WM. Optimized temporal pattern of brain stimulation designed by computational evolution. Sci Transl Med. 2017;9(371):eaah3532. https:\/\/doi.org\/10.1126\/scitranslmed.aah3532.","journal-title":"Sci Transl Med"},{"issue":"5","key":"3658_CR130","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/ner.13037","volume":"23","author":"SF Lempka","year":"2020","unstructured":"Lempka SF, Zander HJ, Anaya CJ, Wyant A, Ozinga IV JG, Machado AG. Patient-specific analysis of neural activation during spinal cord stimulation for pain. Neuromodulation. 2020;23(5):572\u201381. https:\/\/doi.org\/10.1111\/ner.13037.","journal-title":"Neuromodulation"},{"issue":"1","key":"3658_CR131","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1152\/jn.00147.2015","volume":"114","author":"TC Zhang","year":"2015","unstructured":"Zhang TC, Janik JJ, Peters RV, Chen G, Ji RR, Grill WM. Spinal sensory projection neuron responses to spinal cord stimulation are mediated by circuits beyond gate control. J Neurophysiol. 2015;114(1):284\u2013300. https:\/\/doi.org\/10.1152\/jn.00147.2015.","journal-title":"J Neurophysiol"},{"issue":"21","key":"3658_CR132","doi-asserted-by":"publisher","first-page":"7745","DOI":"10.1088\/0031-9155\/58\/21\/7745","volume":"58","author":"A Hirata","year":"2013","unstructured":"Hirata A, Hattori J, Laakso I, Takagi A, Shimada T. Computation of induced electric field for the sacral nerve activation. Phys Med Biol. 2013;58(21):7745\u201355. https:\/\/doi.org\/10.1088\/0031-9155\/58\/21\/7745.","journal-title":"Phys Med Biol"},{"issue":"1","key":"3658_CR133","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1049\/htl.2018.5030","volume":"6","author":"N Yousif","year":"2019","unstructured":"Yousif N, Vaizey CJ, Maeda Y. Mapping the current flow in sacral nerve stimulation using computational modelling. Healthc Technol Lett. 2019;6(1):8\u201312. https:\/\/doi.org\/10.1049\/htl.2018.5030.","journal-title":"Healthc Technol Lett"},{"issue":"8","key":"3658_CR134","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1109\/10.775401","volume":"46","author":"WM Grill","year":"1999","unstructured":"Grill WM. Modeling the effects of electric fields on nerve fibers: influence of tissue electrical properties. IEEE Trans Biomed Eng. 1999;46(8):918\u201328. https:\/\/doi.org\/10.1109\/10.775401.","journal-title":"IEEE Trans Biomed Eng"},{"issue":"1","key":"3658_CR135","doi-asserted-by":"publisher","first-page":"016007","DOI":"10.1088\/1741-2552\/aaeb0c","volume":"16","author":"NA Pelot","year":"2019","unstructured":"Pelot NA, Behrend CE, Grill WM. On the parameters used in finite element modeling of compound peripheral nerves. J Neural Eng. 2019;16(1):016007. https:\/\/doi.org\/10.1088\/1741-2552\/aaeb0c.","journal-title":"J Neural Eng"},{"issue":"1","key":"3658_CR136","doi-asserted-by":"publisher","first-page":"016112","DOI":"10.1063\/5.0308450","volume":"10","author":"DP Marshall","year":"2026","unstructured":"Marshall DP, Upadhye AR, Buyukcelik ON, Shoffstall AJ, Grill WM, Pelot NA. Computational modeling of human vagus nerve stimulation with three-dimensional fascicular morphology. APL Bioeng. 2026;10(1):016112. https:\/\/doi.org\/10.1063\/5.0308450.","journal-title":"APL Bioeng"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03658-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-026-03658-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03658-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T08:04:30Z","timestamp":1787385870000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-026-03658-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":136,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["3658"],"URL":"https:\/\/doi.org\/10.1007\/s12325-026-03658-5","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"7 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Daniel Marshall is a consultant for Neuronoff, Inc. Isha Chugh declares no competing interests. Nazema Siddiqui receives funding from Medtronic Inc., Ethicon (Johnson & Johnson), and Locus Biosciences, royalites from UpToDate, has received speaker honoraria and travel reimbursement from PRIME Education, Inc. and Symposia Medicus, and serves as Treasurer and Executive Committee Member of the American Gynecological & Obstetrical Society (AGOS), and served as a member of the Board of Directors of the American Urogynecological Society (AUGS) (2022\u20132025). Cindy Amundsen receives research funding from NIH\/NICHD, NIH\/NIDDK, FDA, and BlueWind\u00a0Medical, is a consultant and advisory board member for BlueWind Medical, Audaxis Medical, and is on the data safety monitoring board of PCORI. Warren Grill receives research funding, consulting fees, and royalties from Axonics Neuromodulation and Boston Scientific.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}